It can also mediate trastuzumab resistance in BC cell lines by upregulating TGF-β, vimentin and Snail expression, downregulating E-cadherin levels, and increasing the methylation of PTEN gene (Fig. 4a). Here, CDH1 is linked to breast cancer.